From 100 shares in a garage to a ₹1,080 crore listed company.
This guide teaches institutional-grade fundamental analysis from first principles — no prior knowledge assumed. One fictional company, Alpha Technologies, runs through all 17 sections. You will watch its founder's 100 shares of ₹10 face value travel through angel money, venture capital, private equity, an IPO and a decade on the public markets — and learn every concept exactly where it appears in real life.
The Alpha Technologies journey — your running example
Every number below is derived step by step inside the guide. Tap any milestone to preview it; the relevant section teaches the mechanics in full.
2014 · Incorporation — 100 shares · FV ₹10
Founder Ananya Rao registers Alpha Technologies Pvt Ltd with ₹1,000 of share capital. She owns 100%. (Section 1–2)
2016 · Seed round — ₹25 lakh at ₹100/share
An angel buys 20% — share premium, pre-money and dilution appear for the first time. (Section 3)
2018 · Series A — ₹6.25 cr at ₹1,000/share
Crestline Ventures values the company at ₹18.75 cr post-money. The angel's stake is up 10×. (Section 3)
2020 · Series B — ₹50 cr at ₹4,000/share
Meridian Capital (PE) takes 40%. Post-money ₹125 cr. The founder now holds 32% — and is wealthier than ever. (Section 3)
2023 · IPO — ₹150 cr raised at ₹500
A 31:1 bonus first creates 1 crore shares. Fresh issue + offer-for-sale lists Alpha at a ₹600 cr market cap; it opens 30% up. (Section 4–5)
2026 · Listed company — ₹900/share · ₹1,080 cr m-cap
Revenue ₹500 cr, PAT ₹60 cr, ROE 20%, P/E 18×. Now the real analysis begins. (Sections 6–17)
How to use this guide
Use the numbered chips above or the Previous / Next buttons at the bottom of every section. The gold bar tracks your progress.
Tap accordions to expand definitions, switch tabs on the financial statements, tick the forensic checklists, and play with the dilution and DCF calculators.
Every major metric follows one discipline: definition → formula → Alpha example → what good and bad look like → industry exceptions → common mistakes → how professionals use it.
The Complete Life of a Company
Before any ratio means anything, you must understand what a company is, why it issues shares, and how its capital is structured. Everything in investing flows from ownership.
What is a company?
A company is a separate legal person created by law. It can own assets, borrow money, sign contracts, sue and be sued — independently of the humans who own it. Its ownership is divided into identical units called shares (equity). Whoever holds shares owns a proportional slice of everything the company is and will become.
The owners' claim. Shareholders are paid last — after employees, suppliers, lenders and tax — but keep everything that remains. Unlimited upside, last-in-line downside.
Borrowed money. Lenders get fixed interest and repayment first, but never share in the upside. Debt is a contract; equity is a residual.
A shareholder can lose only what they invested. If Alpha collapses owing ₹500 cr, Ananya's house is safe. This single legal idea is what makes large-scale risk-taking — and stock markets — possible.
The share capital ladder
Indian company law defines a precise hierarchy of "share capital." Analysts confuse these constantly; you should never.
| Layer | Meaning | Alpha at incorporation |
|---|---|---|
| Authorized capital | The legal maximum the charter permits the company to issue. A ceiling, not money. | ₹50,00,000 (5,00,000 sh × ₹10) |
| Issued capital | The portion actually offered to investors so far. | ₹1,000 (100 sh) |
| Subscribed capital | The portion investors agreed to take up. Usually = issued. | ₹1,000 |
| Paid-up capital | The portion investors have actually paid for. This sits on the balance sheet. | ₹1,000 |
Outstanding shares, treasury shares & free float
Outstanding shares
All shares currently held by investors. This is the number used for EPS and market cap. Alpha today: 1,20,00,000 shares.
Treasury shares
Shares a company bought back and holds itself (common in the US; in India bought-back shares must be extinguished). They carry no vote, no dividend, and are excluded from EPS.
Free float
Shares actually available for public trading = outstanding − promoter/strategic locked-in holdings. Index weights (Nifty, Sensex) use free-float market cap. Low float → violent price swings on small volumes.
Promoter holding
India-specific term for founders/controlling family. High, stable promoter holding signals skin in the game; pledged promoter shares signal stress.
Who owns a listed company? Alpha's shareholding pattern (2026)
Listed companies disclose this split (promoter / FII / DII / public) every quarter. Rising institutional holding is a quality signal; rising promoter pledging or steady promoter selling is a warning.
Share Fundamentals — The Many "Values" of One Share
A single share carries at least eight different "values." Beginners mix them up; professionals know each answers a different question.
| Value | What it answers | How it's set | Alpha (2026) |
|---|---|---|---|
| Face value (par) | Accounting label per share | Fixed in charter (₹1/₹2/₹5/₹10) | ₹10 |
| Issue price | What investors paid the company | Face value + securities premium | ₹500 (IPO) |
| Book value / share | Accounting net worth per share | Net worth ÷ shares | ₹250 |
| Market price | What the last buyer paid | Live supply & demand | ₹900 |
| Intrinsic value | What the business is truly worth | PV of future cash flows (est.) | analyst's job (§12) |
| Liquidation value | Worth if shut down today | Fire-sale assets − all liabilities | usually < book |
| Replacement value | Cost to rebuild from scratch | Current cost of assets | basis of Tobin's Q |
| Fair value | Price a willing buyer/seller agree | Valuation standards (Ind AS 113) | context-specific |
Face value ₹10 has been constant since 2014, while market price went ₹10 → ₹100 → ₹1,000 → ₹4,000 → ₹500 (post-bonus) → ₹900. Face value tells you nothing about worth — it is an accounting unit used to compute dividends ("200% dividend" = ₹20 on FV ₹10) and split ratios.
Corporate actions — how share counts change
Stock split divides each share into smaller pieces. FV ₹10 → ₹2 means 1 share becomes 5; price divides by 5; your wealth is unchanged. Purpose: improve liquidity and affordability.
Splits change nothing fundamental — EPS, book value/share and dividend/share all divide by the same factor. Any "split rally" is sentiment, not value.
Reverse split (consolidation) merges shares: 10 shares of ₹1 FV → 1 share of ₹10. Often used by penny stocks to escape "below ₹10" optics or exchange minimums — frequently a red flag about what management is hiding.
Bonus shares are free shares issued by converting accumulated reserves into share capital. Shareholder wealth is unchanged; the pie is cut into more slices.
3,12,500 shares × 32 = 1,00,00,000 shares. Reserves fell ₹9.69 cr; share capital rose ₹9.69 cr; net worth identical. Done to create a sensible share count before the IPO.
Difference vs split: bonus keeps FV constant and capitalizes reserves; split reduces FV and touches no reserves.
Rights issue: existing shareholders get the right to buy new shares, pro-rata, usually below market price. It raises fresh capital while letting owners avoid dilution — if they subscribe. Skip your rights and your stake shrinks while the discount transfers value to subscribers.
Buyback: the company purchases its own shares (tender offer or open market) and, in India, extinguishes them. Fewer shares → higher EPS and ownership % for those who stay. It is the mirror image of issuing shares — and a tax-efficient way to return cash.
Good buybacks happen below intrinsic value with surplus cash. Buybacks at bubble prices, or funded by debt while the business starves, destroy value.
Dilution is the silent tax of equity: every new share issued (funding rounds, ESOPs, convertibles, QIPs) shrinks each existing holder's percentage. Anti-dilution clauses protect investors in down rounds by retroactively repricing their entry (full-ratchet or weighted-average), pushing the pain onto founders.
Section 3's calculator lets you feel dilution numerically. Watch the fully-diluted share count (including ESOPs and convertibles), not just outstanding shares.
The Funding Journey — From Bootstrap to Private Equity
Companies climb a capital ladder. Each rung has its own investors, cheque sizes, instruments and maths. Watch Alpha climb it round by round.
The capital ladder
| Stage | Typical investors | What's being funded | Typical cheque (India) |
|---|---|---|---|
| Bootstrapping | Founder savings, revenue | Idea → first product | ₹5L – ₹50L |
| Angel / Seed | Angels, micro-VCs, accelerators | Product-market fit | ₹25L – ₹5 cr |
| Series A | Venture capital funds | Proven model → scale | ₹15 – 80 cr |
| Series B / C | Growth VCs, crossover funds | Market expansion, moat | ₹80 – 800 cr |
| Private equity | PE / buyout funds | Profitable scale, pre-IPO | ₹200 cr+ |
| Strategic | Corporates | Synergy, distribution, tech | varies |
Pre-money, post-money & dilution — the only three formulas you need
Alpha's cap table, round by round
| Holder | Shares | % | Invested |
|---|---|---|---|
| Ananya (founder) | 1,00,000 | 100% | ₹10,00,000 |
| Total · price/share ₹10 (FV) | 1,00,000 | 100% | ₹10 lakh |
Ananya started with 100 shares at incorporation, then subscribed 99,900 more at face value as she poured her savings in. Company value = whatever the cash and code are worth; no external price exists yet.
| Holder | Shares | % | Stake value |
|---|---|---|---|
| Ananya (founder) | 1,00,000 | 80.0% | ₹1.00 cr |
| Angel investor | 25,000 | 20.0% | ₹0.25 cr |
| Total · ₹100/share (₹10 FV + ₹90 premium) | 1,25,000 | 100% | Post-money ₹1.25 cr |
Angel invests ₹25,00,000 for 25,000 new shares. Pre-money = 1,00,000 × ₹100 = ₹1 cr; post-money ₹1.25 cr. The ₹90 above face value is booked as securities premium in reserves. Ananya was diluted 100% → 80%, yet her stake is now priced at ₹1 cr.
| Holder | Shares | % | Stake value |
|---|---|---|---|
| Ananya (founder) | 1,00,000 | 53.3% | ₹10.00 cr |
| Angel | 25,000 | 13.3% | ₹2.50 cr |
| Crestline Ventures (VC) | 62,500 | 33.3% | ₹6.25 cr |
| Total · ₹1,000/share | 1,87,500 | 100% | Post-money ₹18.75 cr |
VC invests ₹6.25 cr at ₹1,000/share (pre-money ₹12.5 cr). The angel's ₹25L is already marked at ₹2.5 cr — 10× on paper. Note: everyone's percentage falls, everyone's value rises. That is what a good up round looks like.
| Holder | Shares | % | Stake value |
|---|---|---|---|
| Ananya (founder) | 1,00,000 | 32.0% | ₹40 cr |
| Angel | 25,000 | 8.0% | ₹10 cr |
| Crestline Ventures (VC) | 62,500 | 20.0% | ₹25 cr |
| Meridian Capital (PE) | 1,25,000 | 40.0% | ₹50 cr |
| Total · ₹4,000/share | 3,12,500 | 100% | Post-money ₹125 cr |
PE invests ₹50 cr at a ₹75 cr pre-money. The founder is below 50% for the first time — control now rests on board seats and shareholder agreements, not raw majority.
Defaults reproduce Alpha's Series B. Try a down round: cut pre-money to 40 and watch the founder's slice get crushed.
Instruments & special situations
Convertible notes
SAFE (Simple Agreement for Future Equity)
Bridge rounds
Up rounds vs down rounds & anti-dilution
Exit scenarios — how private investors get paid
IPO Masterclass — The Day a Company Goes Public
An IPO converts privately negotiated ownership into publicly traded shares. It is part fundraising, part exit, part marketing event — and the moment market capitalization is born.
Why companies go public
Raise large growth money without repayment.
Early investors and employees convert paper into cash.
Listed shares can fund acquisitions and ESOPs.
Disclosure, governance and a public price tag.
The process — Alpha's 2023 IPO
Appoint merchant bankers
Investment banks (book-running lead managers) value the company, draft the prospectus (DRHP → RHP), market the issue and underwrite execution.
Structure the issue — fresh vs OFS
Alpha sells 20,00,000 fresh shares (₹100 cr goes to the company) plus a 10,00,000-share offer-for-sale by Meridian PE (₹50 cr goes to the seller, not Alpha). Always check this split — fresh funds growth; OFS is purely an exit.
Price band & book building
Band set at ₹490–500. Investors bid quantity + price within the band over 3 days; demand discovery ("book building") sets the final cut-off price: ₹500.
Anchor investors
One day before opening, large institutions are allotted shares at the issue price (with a 30/90-day lock-in) to signal confidence and seed the book.
Allotment by category
SEBI reserves the book: QIB 50% (mutual funds, FIIs, insurers), NII/HNI 15%, Retail 35% (bids up to ₹2 lakh, lot-based, lottery if oversubscribed).
Listing day
Alpha lists at ₹650 — a 30% listing gain over ₹500. Had sentiment soured, a listing loss was equally possible: listing price is demand-driven, not merit-driven.
| Item | Value |
|---|---|
| Shares pre-IPO (after 31:1 bonus) | 1,00,00,000 |
| Fresh issue @ ₹500 | +20,00,000 → ₹100 cr to company |
| OFS by PE @ ₹500 | 10,00,000 → ₹50 cr to Meridian |
| Shares post-IPO | 1,20,00,000 |
| Market cap at issue price ₹500 | ₹600 cr |
| Market cap at listing ₹650 | ₹780 cr |
Where billionaires (on paper) come from
| Holder | Invested | Shares post-IPO | Value @ ₹500 | Multiple |
|---|---|---|---|---|
| Ananya (founder) | ₹10 lakh | 32,00,000 (26.7%) | ₹160 cr | 1,600× |
| Angel (2016) | ₹25 lakh | 8,00,000 | ₹40 cr | 160× |
| Crestline VC (2018) | ₹6.25 cr | 20,00,000 | ₹100 cr | 16× |
| Meridian PE (2020) | ₹50 cr | 30,00,000 + ₹50 cr cash | ₹150 cr + ₹50 cr | 4× |
"Paper wealth" because lock-ins apply: under current SEBI norms the promoter's minimum contribution (20% of post-issue capital) is locked for 18 months, other pre-IPO holders for 6 months, and anchor allotments for 30–90 days. Watch lock-in expiry dates — supply often hits the price.
IPO vocabulary that moves money
Grey Market Premium (GMP)
How IPO valuation is actually set
Post-listing dynamics
Market Capitalization & Enterprise Value
Market cap prices the equity. Enterprise value prices the whole business. Confusing the two is the most common valuation error in retail investing.
Size buckets
| Bucket | India (AMFI/SEBI rule) | Global rough guide | Character |
|---|---|---|---|
| Large cap | Top 100 companies by m-cap | > $10B | Stable, liquid, heavily researched, lower growth |
| Mid cap | Ranks 101–250 | $2–10B | Growth + emerging moats; the sweet spot and the trap |
| Small cap | Rank 251 onwards | $250M–2B | High growth, thin coverage, illiquidity risk |
| Micro / nano | Bottom of the small-cap list | < $250M / < $50M | Lottery-ticket dynamics; manipulation-prone |
AMFI refreshes the India cut-offs every six months from actual ranks — the rupee thresholds drift with the market, the ranks don't. Alpha at ₹1,080 cr sits deep in small-cap territory.
Enterprise value — the takeover price
If you bought every Alpha share, you'd also inherit its debts and its cash. EV is what an acquirer truly pays for the operating business:
Why debt adds
Buy the equity and the lenders are now your problem — repaying ₹100 cr is part of the purchase. Two companies with identical market caps but different debt are wildly different purchases.
Why cash subtracts
The ₹40 cr in Alpha's bank comes with the deal — an instant partial refund. A cash-rich company is cheaper than its market cap suggests.
Company A: m-cap ₹1,000 cr, debt ₹900 cr, cash ₹50 cr → EV ₹1,850 cr. Company B: m-cap ₹1,000 cr, no debt, cash ₹400 cr → EV ₹600 cr. Same "price" on a screener; B costs an acquirer one-third of A. This is why professionals compare EV/EBITDA, never P/E, across firms with different debt loads (§12).
Financial Statements Masterclass
Three documents tell a company's whole story: what it owns and owes (balance sheet), what it earned (income statement), and where cash actually moved (cash flow). Here are Alpha's FY2026 statements, line by line.
A snapshot at one instant (31 Mar 2026). It always balances: Assets = Liabilities + Equity, because every asset is funded by someone's money.
| Assets (₹ cr) | FY26 |
|---|---|
| Net fixed assets (plant, equipment, after depreciation) | 180 |
| Capital work-in-progress (assets under construction) | 20 |
| Goodwill & intangibles (acquisitions, software, brands) | 30 |
| Inventory (raw material → finished goods) | 70 |
| Trade receivables (sold, not yet collected) | 90 |
| Cash & equivalents | 40 |
| Other assets (deposits, deferred tax asset, investments) | 70 |
| Total assets | 500 |
| Equity & liabilities (₹ cr) | FY26 |
|---|---|
| Share capital (1.2 cr sh × ₹10 FV) | 12 |
| Reserves & surplus (premium + retained profits) | 288 |
| Total equity (net worth) | 300 |
| Borrowings (long-term 80 + short-term 20) | 100 |
| Trade payables (owed to suppliers) | 60 |
| Other liabilities (provisions, deferred tax liability) | 40 |
| Total equity + liabilities | 500 |
Line items that confuse everyone
A film over one period (FY26). Revenue at the top, a series of cost subtractions, profit at the bottom.
| Income statement (₹ cr) | FY26 | % of revenue |
|---|---|---|
| Revenue from operations | 500 | 100% |
| − Cost of goods/services (materials, cloud, delivery) | (275) | 55% |
| Gross profit | 225 | 45% |
| − Selling, general & admin | (80) | 16% |
| − R&D / product | (25) | 5% |
| EBITDA | 120 | 24% |
| − Depreciation & amortization (non-cash) | (25) | 5% |
| EBIT / operating profit | 95 | 19% |
| − Interest (finance costs) | (15) | 3% |
| Profit before tax | 80 | 16% |
| − Tax @ 25% | (20) | 4% |
| Profit after tax (PAT) · EPS = 60 ÷ 1.2 cr = ₹50 | 60 | 12% |
Depreciation vs amortization — and why they're "non-cash"
Where cash actually moved — the statement accruals cannot fake for long. Three buckets:
| Cash flow statement (₹ cr) | FY26 |
|---|---|
| Operating (CFO): PAT 60 + D&A 25 − working-capital increase 15 | +70 |
| Investing (CFI): capex −40, investments −5 | −45 |
| Financing (CFF): dividends −12, net borrowing −3 | −15 |
| Net change in cash (opening 30 → closing 40) | +10 |
The healthiest pattern for a mature company: CFO strongly + CFI −(growth capex) CFF −(returning cash). The scariest: CFO negative while CFF positive — the company survives on new money. Section 10 goes deep.
PAT links P&L → balance sheet
FY26 PAT ₹60 cr − dividends ₹12 cr = ₹48 cr added to reserves, growing equity.
PAT also opens the cash flow statement
CFO starts from profit, reverses non-cash items, adjusts working capital.
Closing cash returns to the balance sheet
The ₹40 cr cash line is the cash-flow statement's ending balance.
Capex builds assets; depreciation drains them
CFI's capex raises fixed assets/CWIP; the P&L's D&A writes them down over years.
Revenue & Profitability — The Margin Waterfall
Profit is not one number; it is a staircase. Each step down reveals a different layer of business quality — product economics, operating discipline, capital structure, tax.
100%
45%
24%
19%
16%
12%
Alpha FY26, ₹ crore. Every rupee of revenue loses 88 paise on the way down — the question is where and why.
Each margin, decoded
Gross margin — product economics
Measures pricing power and input costs before any overheads. Software 70–90% FMCG 40–55% Retail/distribution 5–25%. A falling gross margin means competition or input inflation is winning.
EBITDA margin — operating engine, pre-accounting
Earnings before interest, tax, depreciation, amortization — proxy for operating cash power, comparable across capital structures. Beware: for asset-heavy firms EBITDA flatters, since depreciation is a real future cost ("EBITDA is profit before the bad stuff").
Operating (EBIT) margin — the honest one
Includes D&A, excludes financing and tax. The cleanest measure of how well operations convert sales into profit. Stable or rising EBIT margin through a downcycle is a moat signature (§13).
Net margin — what shareholders keep
After everything. Compare only within an industry: 12% is excellent for retail, mediocre for software. Watch for net margin propped up by "other income" (treasury gains) rather than operations.
Unit economics — profitability before the P&L can see it
Contribution margin
Profit per incremental unit before fixed costs. Positive contribution + scale → operating leverage; negative contribution means growth literally manufactures losses.
CAC, LTV & cohorts
Alpha's SaaS line: CAC ₹4,000; ARPU ₹500/month at 80% GM; 2% monthly churn → ~50-month life → LTV ₹20,000 → LTV/CAC 5×, payback 10 months. Cohort analysis tracks each joining-month's customers over time — flat or rising cohort revenue curves are the strongest evidence of product-market fit.
Return Metrics — How Hard Does Capital Work?
Margins ask "how much profit per rupee of sales?" Returns ask the deeper question: "how much profit per rupee of capital?" Long-run stock returns gravitate toward returns on capital.
| Metric | Formula | Alpha FY26 | Answers | Benchmark |
|---|---|---|---|---|
| ROE | PAT ÷ Equity | 60/300 = 20% | Return on shareholders' money | >15% good · >20% excellent |
| ROCE | EBIT ÷ (Equity + Debt) | 95/400 = 23.8% | Return on all long-term capital, pre-financing | > cost of capital (~12–14%) |
| ROA | PAT ÷ Total assets | 60/500 = 12% | Asset efficiency (key for banks) | industry-specific |
| ROIC | NOPAT ÷ Invested capital | 71.25/360 = 19.8% | Return on capital actually deployed in operations | ROIC − WACC = value creation |
| ROI | Gain ÷ Cost | project-level | Generic project return | context |
NOPAT = EBIT × (1 − tax) = 95 × 0.75 = ₹71.25 cr. Invested capital = equity 300 + debt 100 − non-operating cash 40 = ₹360 cr.
DuPont analysis — opening the ROE engine
ROE is three machines multiplied together. DuPont tells you which machine produces the return — and whether it's the dangerous one.
Net margin 12%
Earn more per sale. The pharma/luxury path: high-margin, moderate turnover.
Asset turnover 1.0×
Sell more per rupee of assets. The retail path: razor margins, furious turnover.
Equity multiplier 1.67×
Amplify with debt. The fragile path: a 30% ROE built on 5× leverage is a different animal from a debt-free 30%.
Quality 20% ROE
14% margin × 1.4× turnover × 1.0× leverage. No debt; the return is pure business quality. Survives recessions, compounds quietly.
Fragile 20% ROE
4% margin × 1.0× turnover × 5.0× leverage. The same headline ROE — but one bad year of margins wipes equity. DuPont exposes the difference instantly.
What returns reveal about management
Industry exceptions
Leverage, Liquidity & Survival Risk
Debt is an amplifier: it magnifies returns on the way up and destroys equity on the way down. Most permanent capital loss in markets traces back to balance sheets, not bad products.
| Ratio | Formula | Alpha FY26 | Healthy zone | Danger zone |
|---|---|---|---|---|
| Debt-to-equity | Total debt ÷ Equity | 100/300 = 0.33 | < 0.5 comfortable | > 2 fragile (non-financials) |
| Current ratio | Current assets ÷ Current liabilities | 240/120 = 2.0 | 1.5 – 2.5 | < 1 = bills exceed near-cash |
| Quick ratio | (CA − Inventory) ÷ CL | 170/120 = 1.4 | > 1 | < 0.5 |
| Interest coverage | EBIT ÷ Interest | 95/15 = 6.3× | > 4× safe | < 2× — one bad year from default |
| Net debt / EBITDA | (Debt − Cash) ÷ EBITDA | 60/120 = 0.5× | < 2× | > 4× — lender territory |
The three ways leverage kills
Liabilities outgrow asset values; equity is wiped. Watch persistent losses + rising debt + shrinking net worth.
Solvent on paper, but cash isn't there today. Profitable firms die of liquidity — payroll doesn't accept receivables.
Debt maturing into a frozen credit market or a downgrade. Check the maturity schedule in the annual report — lumpy near-term maturities are the fuse.
Working capital — the daily oxygen
Funds the gap between paying suppliers and collecting from customers. Growing companies often consume cash because they grow — receivables and inventory scale with sales. Negative working capital can be a superpower (customers pay before suppliers are paid — FMCG, platforms) or a death spiral (unpaid suppliers), context decides.
Industry differences — when "high debt" is normal
Cash Flow Analysis — Profit Is Opinion, Cash Is Fact
Accrual accounting records revenue when earned, not when paid. That flexibility is useful — and abusable. Cash flow is the audit trail that keeps profit honest.
Free cash flow — the owner's number
Owner earnings (Buffett)
PAT + D&A − maintenance capex ± working-capital changes. The cash an owner could pocket while keeping competitive position intact. Distinguishing maintenance capex from growth capex is the art — growth capex is a choice, maintenance is a tax.
Why profit ≠ cash
Sell ₹100 cr on credit: profit recognized today, cash maybe next year (receivables ↑). Build inventory: cash out, no P&L impact yet. Buy a machine: cash out now, P&L cost spread over 10 years. Each gap is legitimate — until it isn't.
Cash conversion cycle — how long money is trapped
Alpha's rupee spends 79 days inside the business between paying suppliers and collecting from customers. Shorter is better; a lengthening CCC while sales grow is an early-warning siren — fake sales park themselves in receivables.
The fraud detector: CFO vs PAT
Healthy: Alpha
| FY24 | FY25 | FY26 | |
|---|---|---|---|
| PAT | 42 | 51 | 60 |
| CFO | 48 | 59 | 70 |
| CFO/PAT | 114% | 116% | 117% |
Cumulative CFO ≥ cumulative PAT over 5 years (D&A makes >100% normal). Profits are turning into bank balance.
Suspect pattern
| Y1 | Y2 | Y3 | |
|---|---|---|---|
| PAT | 40 | 55 | 75 |
| CFO | 22 | 10 | −5 |
| Receivable days | 70 | 110 | 165 |
Booming "profits", vanishing cash, ballooning receivables — the classic signature of aggressive or fictitious revenue (Satyam's playbook, §14).
Reading the three buckets like a pro
Shareholder Value Creation — Dividends, Buybacks & Compounding
A company creates value by earning high returns; it delivers value through capital allocation: reinvest, acquire, repay debt, buy back, or pay out. Judging those choices is half of investing.
Dividends
Cash returned per share. Low payout + high ROCE = rational reinvestment. High payout + no growth = a bond-like "cash cow". A yield that looks huge because the price collapsed is a trap, not a gift. Special dividends return one-off windfalls (asset sales) without committing to a higher run-rate.
Buybacks
Value-creating only when shares trade below intrinsic value and the cash is genuinely surplus. Buybacks that merely mop up ESOP issuance, or are done at euphoric prices, transfer wealth from continuing holders to sellers.
The capital-allocation hierarchy
1 · Reinvest in the core
If incremental ROIC > WACC, every retained rupee compounds. This is Alpha's current mode (payout only 20%).
2 · Acquire — carefully
Most acquisitions destroy value via overpayment (the goodwill graveyard, §14). Judge management's deal history ruthlessly.
3 · Repay debt
A guaranteed return equal to the interest rate, plus survival insurance.
4 · Buy back below intrinsic value
Concentrates ownership for those who stay.
5 · Pay dividends
The honest default when no better use exists.
Total shareholder return & the compounding engine
Try 25 vs 15 years: the final decade typically creates more wealth than the first two combined. Compounding is back-loaded — which is why holding quality matters more than trading it.
Valuation Masterclass — Price Is What You Pay, Value Is What You Get
A great company bought at the wrong price is a bad investment. Valuation is the discipline of estimating what a business is worth — through relative multiples (vs peers & history) and absolute models (DCF) — then demanding a margin of safety.
The multiples toolkit — Alpha at ₹900
| Multiple | Formula | Alpha | Best for | Watch out |
|---|---|---|---|---|
| P/E | Price ÷ EPS | 900 ÷ 50 = 18× | Stable, profitable firms | Meaningless on losses; distorted by one-offs |
| Forward P/E | Price ÷ next-yr EPS | 900 ÷ 59 ≈ 15.3× | Pricing the future, not the past | Estimates are guesses — verify the "E" |
| PEG | P/E ÷ EPS growth % | 18 ÷ 18 ≈ 1.0 | Comparing growth stocks | Assumes growth is durable & linear |
| P/B | Price ÷ Book value/sh | 900 ÷ 250 = 3.6× | Banks, financials, asset-heavy | Book ≠ worth for asset-light firms |
| EV/EBITDA | EV ÷ EBITDA | 1,140 ÷ 120 = 9.5× | Comparing across capital structures | EBITDA ignores capex & interest reality |
| EV/Sales | EV ÷ Revenue | 1,140 ÷ 500 = 2.3× | Loss-making / early-stage | Revenue without profit can be bought |
| P/S | Mcap ÷ Revenue | 1,080 ÷ 500 = 2.2× | Quick screens | Ignores debt entirely — prefer EV/Sales |
| FCF yield | FCF ÷ Mcap | 30 ÷ 1,080 = 2.8% | Cash-based reality check | Lumpy capex years distort it |
Relative valuation
Compare multiples vs peers and vs the company's own 5–10 yr history. Fast, market-grounded, great for spotting outliers. Weakness: if the whole sector is overpriced, "cheap vs peers" still loses money.
Absolute valuation (DCF)
Value = present value of all future free cash flows. Forces you to make assumptions explicit. Weakness: tiny input changes swing the answer — treat it as a range generator, not an oracle.
DCF, step by step
1 · Project FCF
5–10 yrs of free cash flow. Alpha: ₹30 cr growing ~18%.
2 · Pick discount rate
WACC — the return investors require for the risk.
3 · Terminal value
Worth of all cash flows beyond year 5–10.
4 · Discount & sum
PV of FCFs + PV of terminal = Enterprise value.
5 · To equity
− Net debt ÷ shares = intrinsic value per share.
WACC — the discount rate
Equity is the expensive capital because shareholders bear first loss. Higher business risk → higher β → higher WACC → lower present value. India's risk-free rate (10-yr G-Sec ~7%) sets the floor.
Terminal value — handle with care
TV is often 60–75% of the whole DCF — which means most of your "precise" valuation is a guess about the distant future. If your answer collapses when g moves from 5% to 4%, you don't have a thesis, you have a spreadsheet.
Default inputs value Alpha well below ₹900 — deliberately. Today's FCF (₹30 cr) is depressed by heavy growth capex. Try FCF ₹55 cr (closer to owner earnings) or growth 22%: the verdict flips. That sensitivity is the lesson — DCF tells you which assumptions you're paying for.
Margin of safety
Because every valuation is wrong, the buffer is the strategy. A 30% margin of safety means your future can disappoint by a third before you lose. Risk control happens at purchase, not in the stop-loss.
Business Quality — Moats, Industry Structure & Management
Numbers tell you what happened; quality analysis tells you whether it will keep happening. High returns on capital attract competitors — a moat is whatever stops them from eroding those returns.
The five great moats
Network effects
Each user makes the product more valuable to others (exchanges, payment networks, marketplaces). Winner-take-most dynamics; near-impossible to displace once critical mass is reached.
StrongestBrand power
A promise that commands a price premium and repeat purchase without re-convincing (FMCG, luxury). Visible in gross margins and ad-spend efficiency, built over decades.
DurableSwitching costs
Leaving is painful — retraining, data migration, regulatory revalidation (core banking software, ERPs). Shows up as >100% net revenue retention and pricing power on renewals.
StickyScale advantages
Fixed costs spread over the largest volume base; distribution reach rivals can't replicate economically. The big get structurally cheaper.
Capital-heavyCost leadership
A process, location or asset advantage that makes you the lowest-cost producer (commodities, logistics). The only safe seat in a price war.
DefensibleNo moat
If customers choose on price alone and entry is easy, high ROCE is a temporary accident. Expect mean reversion — and value the business accordingly.
FragilePorter's five forces — reading industry structure
1 · Rivalry
Many similar players + slow growth + high fixed costs = price wars (telecom, airlines). Few rational players = pricing discipline.
2 · New entrants
How hard is entry? Licences, capital, brand, distribution all raise the wall. Easy entry caps everyone's margins.
3 · Supplier power
Concentrated suppliers squeeze you (aircraft makers vs airlines). Fragmented suppliers get squeezed.
4 · Buyer power
Few large customers can dictate prices & payment terms — check customer-concentration disclosures (>20% from one client is a flag).
5 · Substitutes
The outside threat: UPI vs cards, OTT vs cable. Substitutes kill industries quietly, then suddenly.
The output
Favourable structure → industry ROCE persistently above cost of capital. Hostile structure → even great managers earn poor returns. Pick ponds where fish are big.
Management quality & governance
Competence — the track record
Judge by outcomes over a full cycle: ROIC vs cost of capital, per-share value growth, acquisitions that actually earned their keep, guidance vs delivery. Read 5 years of annual-report letters — did they do what they said?
Integrity — the alignment
Promoter holding high and unpledged; salaries reasonable vs profits; minimal related-party transactions; clean auditor opinions; independent board that actually dissents; conservative accounting choices.
| Governance signal | Comfort | Red flag |
|---|---|---|
| Promoter pledge | 0% | >20% of holding pledged |
| Auditor | Stable, reputed, clean opinions | Frequent resignations / qualifications |
| Related-party deals | Minimal, arm's length | Loans to promoter entities, royalty creep |
| Remuneration | Tied to ROCE / EPS growth | Rising while profits fall |
| Capital allocation | Buybacks below value, rational capex | Diworsification into unrelated glamour sectors |
Forensic Accounting — Catching Manipulation Before It Catches You
Most frauds aren't hidden — they're printed in the annual report, waiting for someone to reconcile profit with cash. Learn the standard tricks and the cross-checks that expose them.
The manipulation playbook
Aggressive revenue recognition
Booking sales before they're earned — long-term contracts front-loaded, sales with return rights, "bill and hold". Tell: receivables growing much faster than revenue; unbilled revenue ballooning.
Channel stuffing
Forcing inventory onto dealers at quarter-end to book sales. Borrows from next quarter until the channel chokes. Tell: spiking quarter-end receivables, rising dealer incentives, later sales returns.
Round tripping
Sales to related entities that route the money back — revenue without economic substance. Tell: growth driven by obscure counterparties, matching purchases & sales with the same group.
Related-party siphoning
Loans & advances to promoter entities, inflated royalty/rent to family firms, assets bought from promoters above fair value. Tell: the related-party-transactions note — always read it.
Expense games
Capitalising operating costs as assets (so they skip the P&L), stretching depreciation lives, one-time "exceptional" losses every single year. Tell: rising intangibles/CWIP with no products; margins detached from peers.
Balance-sheet dressing
Fake or restricted cash, undisclosed pledges & guarantees, window-dressing debt at year-end. Tell: high "cash" alongside high-cost borrowing — why borrow at 12% while holding idle cash?
Three cases every investor must know
India's largest accounting fraud. ₹7,000+ crore of cash on the balance sheet simply didn't exist — invoices and bank statements were fabricated for years. The chairman confessed in a letter describing it as "riding a tiger, not knowing how to get off". Lesson: cash can be faked; cross-check interest income against reported cash. ₹5,000 cr earning almost no interest is a question, not a footnote.
The SPE machine. Enron parked debt and losses in thousands of off-balance-sheet "special purpose entities" while booking mark-to-market profits on long-term contracts the day they were signed. Equity went from $90 to zero in a year. Lesson: profits that never convert to operating cash, plus complexity no one can explain, is the classic pre-collapse signature.
€1.9 billion that never existed. Wirecard, a DAX-30 fintech, claimed cash in Philippine escrow accounts; auditors finally asked the banks — the accounts were fiction. Short-sellers and journalists had flagged it for years while regulators defended the company. Lesson: when management attacks questioners instead of answering questions, the questioners are usually right.
Interactive forensic checklist — score any company
Industry-Specific Analysis — The Right Metric for the Right Business
Applying P/E to a bank or EV/EBITDA to an insurer is how good analysts make bad calls. Every industry has its own scoreboard — here are twelve playbooks.
Financial businesses
What the business is: borrow at deposit rates, lend higher, survive the credit cycle.
Value on P/B vs ROE, never EV/EBITDA (debt IS the raw material). Provision coverage ratio shows prudence; credit-cost guidance shows honesty.
What the business is: collect premiums today, pay claims tomorrow, invest the float.
What the business is: a bank without deposits — funding risk is the killer.
Check who funds them and for how long — NBFC crises (IL&FS 2018) are liquidity events first, credit events second.
What the business is: rent-collecting real estate distributing ≥90% of cash flows.
Operating businesses
Alpha's own scoreboard: LTV/CAC 5×, payback 10 months — the unit economics that justified its Series B.
Watch pricing per employee and the pyramid (fresher ratio) — margins live there.
Judge over a full cycle: peak-margin years flatter, trough years reveal. Capex announcements precede earnings by 2–3 years.
One bad FDA inspection can erase a year of earnings — regulatory risk is the sector's beta.
Margins are thin and fixed-price contracts carry inflation risk — balance-sheet strength decides who survives delays.
The Professional Investment Framework — From Idea to Decision
Institutions don't rely on brilliance; they rely on process. This is the workflow that turns 5,000 listed companies into a portfolio of 15–25 researched convictions.
The seven-step workflow
1 · Screen
Filter the universe: ROCE > 15%, debt/equity < 1, sales growth > 10%, CFO/PAT > 0.8. 5,000 → ~150 names.
2 · Forensic gate
Section-14 checklist. Any fraud signal = instant reject, regardless of price.
3 · Business deep-dive
Annual reports (5 yrs), moat & Porter analysis, industry scoreboard, channel checks.
4 · Financial model
Rebuild the three statements; project 3–5 yrs; stress-test margins and working capital.
5 · Valuation
DCF range + multiples vs peers/history + reverse-DCF. Set buy-below price.
6 · Score & decide
Weighted scorecard below. Position size follows conviction and risk.
7 · Monitor
Quarterly thesis check: results vs assumptions. Exit triggers written in advance.
The weighted scorecard
| Dimension | Weight | What earns 5/5 | What earns 1/5 |
|---|---|---|---|
| Business quality & moat | 25% | Durable moat, ROCE > 20% across cycle | Commodity product, price-taker |
| Management & governance | 20% | Skilled allocators, zero pledge, clean RPTs | Pledged promoters, auditor churn |
| Financial strength | 25% | CFO/PAT > 0.9, net cash, stable margins | Leverage rising, cash never arrives |
| Valuation comfort | 20% | ≥ 30% below intrinsic range | Priced for perfection |
| Risk profile | 10% | Diversified customers, low regulation risk | One client, one product, one geography |
| Composite | 100% | ≥ 4.0 investable · 3.0–3.9 watchlist · < 3.0 reject | |
Buy · Hold · Sell rules
BUY
Score ≥ 4.0 and margin of safety ≥ 25%. Quality and price must agree — either alone is insufficient.
HOLD
Thesis intact but price has caught up (MoS < 10%), or score dips to 3.5 on fixable issues. Compounding continues; adding stops.
SELL
Thesis broken (moat eroding, governance breach, forensic flag), better opportunity at equal risk, or valuation > 40% above the top of your range.
Portfolio inclusion criteria
Construction discipline
15–25 positions · max 10% in one stock at cost · max 25–30% per sector · initial position 3–5%, scale with evidence · cash is a position when nothing clears the bar.
Written before buying
One-page thesis · the 3 assumptions that must stay true · pre-committed exit triggers · the bear case argued honestly. If you can't write it, you don't own a thesis — you own a ticker.
The Complete Analysis Template — Analyse Any Listed Company
Your reusable one-company dossier. Work through the accordions top to bottom, fill the prompts, and you'll have produced an institutional-grade research note — repeatable for every stock you ever study.
1 · Business analysis
□ What does the company sell, to whom, and why do customers choose it? □ Revenue split by segment / geography / customer concentration. □ Industry size, growth and structure (five forces). □ Moat type and the evidence for it (pricing power, retention, share gains). □ Unit economics: what does one unit of sale earn? □ Key dependencies — suppliers, regulation, technology shifts.
2 · Management & governance analysis
□ Track record: 5-yr promises vs delivery. □ Capital-allocation history — what did they do with every ₹100 of CFO? □ Promoter holding, pledge %, insider buys/sells. □ Related-party transactions and auditor history. □ Board independence; remuneration vs performance. □ Accounting conservatism (depreciation policy, revenue recognition).
3 · Financial analysis (5–10 yrs)
□ Rebuild the three statements in your own sheet. □ DuPont decomposition — what actually drives ROE? □ Forensic checklist (Section 14) passed in full.
4 · Valuation analysis
□ Current multiples vs own 10-yr range and vs peers. □ DCF with explicit assumptions (growth, margin, WACC, terminal g) — output a range. □ Reverse-DCF: what does today's price assume? □ Buy-below price = intrinsic estimate × (1 − required MoS).
5 · Risk analysis
□ Business risks (demand, competition, disruption). □ Financial risks (leverage, refinancing, currency). □ Governance risks. □ Regulatory/political risks. □ For each: probability × impact × your mitigation (price, size, or avoidance).
6 · Scenarios, thesis & decision
| Scenario | Key assumptions | EPS × multiple | Target | Probability |
|---|---|---|---|---|
| Bear | Growth stalls to 8%, margin −300 bps | 55 × 12 | ₹660 | 25% |
| Base | 18% growth sustains, margins steady | 68 × 16 | ₹1,090 | 50% |
| Bull | 22% growth + margin expansion | 75 × 20 | ₹1,500 | 25% |
| Probability-weighted target | ₹1,085 | |||
Worked on Alpha at ₹900: weighted target ₹1,085 → expected upside ~20%, bear-case downside −27%. Reward/risk ≈ 0.8 — below the 2:1 a professional demands. Verdict: quality confirmed, price not yet right → watchlist with a buy-below at ~₹815 (25% MoS on base intrinsic).
□ Write the thesis in 5 sentences. □ List the 3 assumptions that must remain true. □ Pre-commit exit triggers. □ Decision: Buy Watchlist Reject — with position size.